Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Plasmodium vivax cerebral malaria in an adult patient in Sudan

View through CrossRef
Abstract Background Plasmodium vivax infection is rising in sub-Saharan Africa, where Plasmodium falciparum is responsible for more than 90% of malaria cases. While P. vivax is identified as a major cause of severe and cerebral malaria in South east Asia, the Pacific and South America, most of the severe and cerebral cases in Africa were attributed to P. falciparum. Cases of severe malaria due to P. vivax are emerging in Africa. A few severe P. vivax cases were reported in Eastern Sudan and they were underestimated due to the lack of accurate diagnosis, low parasitaemia and seldom use of rapid diagnostic tests (RDTs). Case presentation A 60-year-old Sudanese male presented to the Al Kuwaiti hospital in the Sudan capital Khartoum. On admission, the patient was complaining of fever (measured temperature was 38 °C), sweating, chills, vomiting and confusion in the past 2 days prior to his admission. He rapidly deteriorated into a coma state within 48 h of the admission, with significant neck stiffness. He was admitted to the intensive care unit and was suspected of meningitis. Lumbar puncture was not performed since the patient was suffering from spinal cord disc. Brain CT scan was unremarkable. Several biochemical, haematological tests, and blood film for malaria were performed. The results of the laboratory tests were within the normal range except of mild elevation of the total white blood cell count and a significant decrease in the platelets count. Malaria parasites were seen in the blood film with high parasitaemia (quantified as 3 +++). The patient was diagnosed as P. vivax cerebral malaria based on the positive blood film and the amplification of P. vivax specific 499 bp amplicon using Plasmodium multi-species multiplex Polymerase Chain Reaction (PCR). The patient was treated with quinine 10 mg/kg body weight for 10 days followed by primaquine 15 mg/days PO for 2 weeks. The symptoms subsided within 48 h and the patients was cured and released from the hospital. Conclusions Plasmodium vivax is an emerging cause of cerebral malaria in adults in Sudan and should be considered in the differential diagnosis of cerebral malaria for proper management of patients.
Title: Plasmodium vivax cerebral malaria in an adult patient in Sudan
Description:
Abstract Background Plasmodium vivax infection is rising in sub-Saharan Africa, where Plasmodium falciparum is responsible for more than 90% of malaria cases.
While P.
vivax is identified as a major cause of severe and cerebral malaria in South east Asia, the Pacific and South America, most of the severe and cerebral cases in Africa were attributed to P.
falciparum.
Cases of severe malaria due to P.
vivax are emerging in Africa.
A few severe P.
vivax cases were reported in Eastern Sudan and they were underestimated due to the lack of accurate diagnosis, low parasitaemia and seldom use of rapid diagnostic tests (RDTs).
Case presentation A 60-year-old Sudanese male presented to the Al Kuwaiti hospital in the Sudan capital Khartoum.
On admission, the patient was complaining of fever (measured temperature was 38 °C), sweating, chills, vomiting and confusion in the past 2 days prior to his admission.
He rapidly deteriorated into a coma state within 48 h of the admission, with significant neck stiffness.
He was admitted to the intensive care unit and was suspected of meningitis.
Lumbar puncture was not performed since the patient was suffering from spinal cord disc.
Brain CT scan was unremarkable.
Several biochemical, haematological tests, and blood film for malaria were performed.
The results of the laboratory tests were within the normal range except of mild elevation of the total white blood cell count and a significant decrease in the platelets count.
Malaria parasites were seen in the blood film with high parasitaemia (quantified as 3 +++).
The patient was diagnosed as P.
vivax cerebral malaria based on the positive blood film and the amplification of P.
vivax specific 499 bp amplicon using Plasmodium multi-species multiplex Polymerase Chain Reaction (PCR).
The patient was treated with quinine 10 mg/kg body weight for 10 days followed by primaquine 15 mg/days PO for 2 weeks.
The symptoms subsided within 48 h and the patients was cured and released from the hospital.
Conclusions Plasmodium vivax is an emerging cause of cerebral malaria in adults in Sudan and should be considered in the differential diagnosis of cerebral malaria for proper management of patients.

Related Results

Prevalence, Demographic Patterns, and Seasonal Distribution of Malaria in District Dera Ismail Khan, Pakistan
Prevalence, Demographic Patterns, and Seasonal Distribution of Malaria in District Dera Ismail Khan, Pakistan
Abstract Malaria remains the most significant vector-borne disease worldwide, with over 200 million cases reported annually, causing approximatel...
Musta mere ranniku eesti asunikud malaaria meelevallas
Musta mere ranniku eesti asunikud malaaria meelevallas
At the end of the 19th century, Estonian settlers encountered malaria in the Volga region and Siberia, but outbreaks with the most serious consequences hit Estonians in the Black S...
Malaria epidemiological characteristics and control in Guangzhou, China, 1950–2022
Malaria epidemiological characteristics and control in Guangzhou, China, 1950–2022
Abstract Background Malaria was once widespread in Guangzhou, China. However, a series of control measures have succeeded in eliminating local malar...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Correlation between vivax malaria infection and iron deficiency in children
Correlation between vivax malaria infection and iron deficiency in children
Background Iron deficiency is considered to be a major public health problem around the world due to its high prevalence as well as its effect on growth, development, and infection...
Plasmodium Species and Drug Resistance
Plasmodium Species and Drug Resistance
Malaria is a leading public health problem in tropical and subtropical countries of the world. In 2019, there were an estimated 229 million malaria cases and 409, 000 deaths due ma...

Back to Top